<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2020-1-74-77</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-996</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Случай изолированного IgG4-связанного заболевания легких у подростка</article-title><trans-title-group xml:lang="en"><trans-title>A case of isolated IgG4-related lung disease in a teenager</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сокол</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokol</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilyev</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123056, Москва, Грузинский переулок, 3А</p></bio><bio xml:lang="en"><p>3A, Gruzinsky Lane, Moscow 123056</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кокосадзе</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kokosadze</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 23</p></bio><bio xml:lang="en"><p>23, Kashirskoe Shosse, Moscow 115478</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>КДЦ МЕДСИ на Белорусской</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MEDSI Clinical and Diagnostic Center on Belorusskaya</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>03</month><year>2020</year></pub-date><volume>14</volume><issue>1</issue><fpage>74</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сокол Е.В., Васильев В.И., Кокосадзе Н.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Сокол Е.В., Васильев В.И., Кокосадзе Н.В.</copyright-holder><copyright-holder xml:lang="en">Sokol E.V., Vasilyev V.I., Kokosadze N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/996">https://mrj.ima-press.net/mrj/article/view/996</self-uri><abstract><p>IgG4-связанное заболевание (IgG4-СЗ) – редкое иммуноопосредованное фибровоспалительное заболевание, характеризующееся возникновением узловых образований в одном или нескольких органах и протекающее у большинства пациентов с повышением уровня IgG4 в сыворотке крови и/или в тканях пораженных органов. Основная часть пациентов – пожилые мужчины, а заболевание в большинстве случаев имеет медленно прогрессирующее системное течение. Очень сложны для дифференциальной диагностики случаи изолированного IgG4-связанного поражения внутренних органов, которые встречаются гораздо реже системного варианта заболевания, а проведение биопсии данных органов сопряжено с техническими трудностями и представляет угрозу здоровью пациента. В статье приводится описание именно такого случая. Он интересен с нескольких точек зрения: во-первых, редкой локализацией – изолированное узловое поражение легких; во-вторых, клинико-лабораторными особенностями (дебют в детском возрасте, отсутствие каких-либо иммунологических отклонений – как повышения уровня IgG4 сыворотки, так и снижения содержания компонентов комплемента).</p><p>Клиницистам следует помнить о том, что IgG4-СЗ не всегда имеет системное течение и характерные серологические маркеры. В этих случаях гистологическая верификация диагноза имеет особое значение. При выявлении гистологической картины фибровоспалительной «псевдоопухоли», особенно при наличии множественных узловых образований, в дифференциальную диагностику всегда следует включать IgG4-СЗ. </p></abstract><trans-abstract xml:lang="en"><p>IgG4-related disease (IgG4-RD) is a rare immune-mediated fibroinflammatory disease that is characterized by the occurrence of nodules in one or more organs and proceeds in most patients with the elevated levels of IgG4 in serum and/or in the tissues of the affected organs. The majority of patients are elderly men, and the disease in most cases has a slowly progressing systemic course. The cases of isolated IgG4-related injury to the viscera, which are much less common than the systemic type of the disease, are a very difficult differential diagnosis, and biopsy of these organs is associated with technical difficulties and poses a threat to the patient's health. The paper describes just such a case. It is interesting from several points of view: firstly, a rare site (solitary pulmonary nodular lesion); secondly, clinical and laboratory features (childhood onset, no immunological abnormalities – both higher serum IgG4 levels and lower complement components).</p><p>Clinicians should remember that IgG4-RD does not always have a systemic course and characteristic serological markers. In these cases, histological verification of the diagnosis is of particular importance. If the histological pattern of a fibroinflammatory pseudotumor is identified, especially in the presence of multiple nodules, IgG4-RD should always be included in the differential diagnosis. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>IgG4-связанное заболевание</kwd><kwd>IgG4-связанное заболевание легких</kwd><kwd>клиническое наблюдение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>IgG4-related disease</kwd><kwd>IgG4-related lung disease</kwd><kwd>clinical case</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stone JH, Zen Y, Deshpande V, et al. IgG4-related disease. New Engl J Med. 2012;366(6):539-51. doi: 10.1056/NEJMra1104650</mixed-citation><mixed-citation xml:lang="en">Stone JH, Zen Y, Deshpande V, et al. IgG4-related disease. New Engl J Med. 2012;366(6):539-51. doi: 10.1056/NEJMra1104650</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015 Apr 11; 385(9976):1460-71. doi: 10.1016/S0140-6736(14)60720-0</mixed-citation><mixed-citation xml:lang="en">Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015 Apr 11; 385(9976):1460-71. doi: 10.1016/S0140-6736(14)60720-0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Сокол ЕВ, Васильев ВИ, Пальшина СГ и др. Клинико-лабораторная характеристика IgG4-связанного заболевания и алгоритм его диагностики. Терапевтический архив. 2019;91(5):40-8. doi: 10.26442/00403660.2019.05.000236.</mixed-citation><mixed-citation xml:lang="en">Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Terapevticheskiy Arkhiv = Therapeutic Archive. 2019;91(5):40-8. doi: 10.26442/00403660.2019.05.000236 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheum. 2015 Sep;67(9):2466-75. doi: 10.1002/art.39205</mixed-citation><mixed-citation xml:lang="en">Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheum. 2015 Sep;67(9):2466-75. doi: 10.1002/art.39205</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr; 94(15):e680. doi: 10.1097/MD.0000000000000680</mixed-citation><mixed-citation xml:lang="en">Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr; 94(15):e680. doi: 10.1097/MD.0000000000000680</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen H, Lin W, Wang Q, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014; 43(1):70-4. doi: 10.3109/03009742.2013.822094</mixed-citation><mixed-citation xml:lang="en">Chen H, Lin W, Wang Q, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014; 43(1):70-4. doi: 10.3109/03009742.2013.822094</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hirano K, Kawaba T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Int Med J. 2006;36(1):58- 61. doi: 10.1111/j.1445-5994.2006.01009.x</mixed-citation><mixed-citation xml:lang="en">Hirano K, Kawaba T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Int Med J. 2006;36(1):58- 61. doi: 10.1111/j.1445-5994.2006.01009.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Matsui S, Taki H, Shinoda K, et al. Respiratory involvement in IgG4-related Mikulicz's disease. Mod Rheumatol. 2012 Feb;22(1):31-9. doi: 10.3109/s10165-011-0504-x</mixed-citation><mixed-citation xml:lang="en">Matsui S, Taki H, Shinoda K, et al. Respiratory involvement in IgG4-related Mikulicz's disease. Mod Rheumatol. 2012 Feb;22(1):31-9. doi: 10.3109/s10165-011-0504-x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yi ES, Sekiguchi H, Peikert T, et al. Pathologic manifestations of Immunoglobulin (Ig) G4-related lung disease. Semin Diagn Pathol. 2012 Nov;29(4):219-25. doi: 10.1053/j.semdp.2012.07.002</mixed-citation><mixed-citation xml:lang="en">Yi ES, Sekiguchi H, Peikert T, et al. Pathologic manifestations of Immunoglobulin (Ig) G4-related lung disease. Semin Diagn Pathol. 2012 Nov;29(4):219-25. doi: 10.1053/j.semdp.2012.07.002</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4-related disease. Clin Chest Med. 2019;40(3):583-97. doi: 10.1016/j.ccm.2019.05.005</mixed-citation><mixed-citation xml:lang="en">Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4-related disease. Clin Chest Med. 2019;40(3):583-97. doi: 10.1016/j.ccm.2019.05.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009 Apr;251(1):260-70. doi: 10.1148/radiol.2511080965</mixed-citation><mixed-citation xml:lang="en">Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009 Apr;251(1):260-70. doi: 10.1148/radiol.2511080965</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jinnur PK, Yi ES, Ryu JH, et al. Cavitating lung disease: a novel presentation of IgG4-related disease. Am J Case Rep. 2015 Jul 21;16:478-82. doi: 10.12659/AJCR.894015</mixed-citation><mixed-citation xml:lang="en">Jinnur PK, Yi ES, Ryu JH, et al. Cavitating lung disease: a novel presentation of IgG4-related disease. Am J Case Rep. 2015 Jul 21;16:478-82. doi: 10.12659/AJCR.894015</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kasashima S, Kawashima A, Ozaki S, et al. Clinicopathological features of immunoglobulin G4-related pleural lesions and diagnostic utility of pleural effusion cytology. Cytopathology. 2019 May;30(3): 285-94. doi: 10.1111/cyt.12641</mixed-citation><mixed-citation xml:lang="en">Kasashima S, Kawashima A, Ozaki S, et al. Clinicopathological features of immunoglobulin G4-related pleural lesions and diagnostic utility of pleural effusion cytology. Cytopathology. 2019 May;30(3): 285-94. doi: 10.1111/cyt.12641</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013 Apr;18(3):480-7. doi: 10.1111/resp.12016</mixed-citation><mixed-citation xml:lang="en">Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013 Apr;18(3):480-7. doi: 10.1111/resp.12016</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep; 25(9):1181-92.</mixed-citation><mixed-citation xml:lang="en">Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep; 25(9):1181-92.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kanno A, Masamune A, Okazaki K, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325</mixed-citation><mixed-citation xml:lang="en">Kanno A, Masamune A, Okazaki K, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Matsui S, Yamamoto H, Minamoto S, et al. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir Investigat. 2016;54(2):130-2. doi: 10.1016/j.resinv.2015.09.002</mixed-citation><mixed-citation xml:lang="en">Matsui S, Yamamoto H, Minamoto S, et al. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir Investigat. 2016;54(2):130-2. doi: 10.1016/j.resinv.2015.09.002</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.3109/s10165-011-0571-z</mixed-citation><mixed-citation xml:lang="en">Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.3109/s10165-011-0571-z</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132</mixed-citation><mixed-citation xml:lang="en">Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1624-34. doi: 10.1007/s00259-014-2729-3</mixed-citation><mixed-citation xml:lang="en">Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1624-34. doi: 10.1007/s00259-014-2729-3</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
